Hematology NewsCMML: GM-CSF inhibitor lenzilumab shows early promiseJune 20, 2023CMLAMLMyelodysplastic SyndromeMixed Topics
Oncology PracticeWidespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Patient & Survivor CarePractice ManagementLung CancerBreast CancerGenitourinary CancerNonmelanoma Skin CancerMetastatic Breast Cancer
Hematology NewsASCO honors Hagop Kantarjian, MD, for leukemia researchMay 16, 2023CMLALLAMLBusiness of MedicineMixed TopicsMyelodysplastic Syndrome
Oncology PracticeNumber of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Patient & Survivor CareLung CancerDiversity in MedicineBreast CancerMixed TopicsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Hematology NewsAFib risk with cancer drugs underestimatedApril 12, 2023Breast CancerLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersImmuno-oncologyHodgkin LymphomaAML
Hematology NewsVenetoclax shows promise for r/r hairy cell leukemiaMarch 10, 2023Mixed TopicsCLLAMLCellular Therapy
Hematology News‘Astonishing’ results: Skip salvage chemo, proceed to HSCTDecember 11, 2022AMLTransplant
Hematology NewsASH 2022: New clinical data challenge long-held assumptionsDecember 7, 2022Mixed TopicsTransplantHodgkin LymphomaALLPatient & Survivor CareMantle Cell LymphomaAML
Hematology NewsWorldwide trial seeks to revolutionize pediatric leukemia careOctober 3, 2022AMLALLPediatrics
